Under construction – not a live service

Skip to content

Frontlight Research

Trial site

ASL Roma 2 - UOC Cure Primarie Distretto 4

Roma, 00159, ItalyNot linked to an institution yet

1closed trial

The trials here

What the trial at this site is about, from its registry record.

Conditions: Type 2 diabetes

Closed trials

Completed
DOORS: A Research Study to Understand How Oral Semaglutide Works in People With Type 2 Diabetes Who Change From Dipeptidyl Peptidase-4 Inhibitor (DPP4i) Treatment to Oral Semaglutide in Italy
NCT05755360· Novo Nordisk A/S· Source

Site data: ClinicalTrials.govUpdated 12 Nov 2026

Report an error

Under construction, not live – ASL Roma 2 - UOC Cure Primarie Distretto 4: trial site – Frontlight Research